Drug Safety Pharmacy Database Pilot In Development Under FDA Partnership
Executive Summary
A pilot program designed to track drug safety through a pharmacy-based electronic adverse event system is under development by the Critical Path to Accelerate Therapies Institute as part of a partnership with FDA
You may also be interested in...
Atrovent, Spiriva Safety To Be Tracked In Pharmacy Active Surveillance Pilot
An active drug surveillance system pilot, directed by the Critical Path Institute (C-Path), will track safety and efficacy information for the chronic obstructive pulmonary disorder therapies Atrovent and Spiriva
Drug Sponsors Should Include Women In QT Studies, CERT’s Woosley Says
QT interval prolongation studies should include more women because of gender differences in cardiac sensitivity to drugs, University of Arizona Center for Education and Research on Therapeutics (AZCERT) Director Raymond Woosley said
Drug Sponsors Should Include Women In QT Studies, CERT’s Woosley Says
QT interval prolongation studies should include more women because of gender differences in cardiac sensitivity to drugs, University of Arizona Center for Education and Research on Therapeutics (AZCERT) Director Raymond Woosley said